GEMTESA is the first and only beta-3 agonist approved for the treatment of men with OAB symptoms who are receiving pharmacological therapy for BPH
Mankind Pharma will have exclusive rights to register, import, market, sell and distribute sintilimab in India
This facility is considered to be in a minimally acceptable state of compliance with regard to current GMP
The company will receive an upfront payment of Euro 100 million (Rs. 880 crores) for product development and site approval from European authorities
This approval is a significant achievement in expanding the availability of this critical therapeutic,
This curated geriatric care package - Varishtha Aarogya Vardaan -- includes a comprehensive range of essential blood tests specifically curated for seniors.
The transaction is expected to result in approximately $175 million to support further development of IMG-007
Exploring new opportunities within the fast-growing market of microfluidics
The TPE Tourniquet and TPE Esmark Bandages are renowned for their single-use design,
Subscribe To Our Newsletter & Stay Updated
